Haemonetics Corp. | Mutual Funds

Mutual Funds that own Haemonetics Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Mid Cap ETF
1,426,542
2.76%
1,152
0.32%
09/06/2018
American Funds Small Cap World Fund
1,378,500
2.67%
1,378,500
0.41%
06/30/2018
Vanguard Total Stock Market Index Fund
1,315,769
2.54%
1,380
0.02%
07/31/2018
Vanguard Small Cap Index Fund
1,313,489
2.54%
17,362
0.15%
07/31/2018
iShares Russell 2000 ETF
1,129,452
2.19%
-603
0.26%
09/06/2018
Neuberger Berman Genesis Fund
1,093,222
2.12%
36,564
1.05%
06/30/2018
Franklin Growth Fund
1,000,000
1.94%
0
0.7%
03/31/2018
Black Creek Global Leaders Fund
967,369
1.87%
85,874
5.61%
06/30/2017
Government Pension Fund - Global (The)
953,373
1.84%
443,128
0.01%
12/31/2017
Vanguard Explorer Fund
894,858
1.73%
-223,509
0.6%
06/30/2018

About Haemonetics

View Profile
Address
400 Wood Road
Braintree Massachusetts 02184
United States
Employees -
Website http://www.haemonetics.com
Updated 07/08/2019
Haemonetics Corp. is a healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software.